|
|||||
|
|
Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients |
|
| Authors: | J.R. Marcelin J.W. Wilson R.R. Razonable The Mayo Clinic Hematology/Oncology Transplant Infectious Diseases Services |
| Affiliation: | 1. Department of Medicine, Mayo Clinic, , Rochester, Minnesota, USA;2. Division of Infectious Diseases, Mayo Clinic, , Rochester, Minnesota, USA |
| Abstract: | |
| Keywords: | ribavirin RSV immunocompromised patients respiratory syncytial virus |